Search clinical trials for: Multi-drug resistant tuberculosis (MDR-TB)

Total 5978 results

St George's, University of London

Unknown

Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections (TIKA_TB)

Tuberculosis (TB)

United Kingdom
Mahidol University

Completed

The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma (Simvastatin)

Asthma

Thailand
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371

Tuberculosis | Tuberculosis, Pulmonary

United States
University of KwaZulu
Centre for the AIDS Programme of Research in South Africa

Recruiting

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB (ORCHID)

Tuberculosis | Hiv

South Africa
National Institute of Allergy and Infectious Diseases...

Completed

A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding

Mycobacterium Tuberculosis

Brazil
Cukurova University

Completed

Preoperative Melatonin or Vitamin C Administration on Postoperative Analgesia

Postoperative Pain

Turkey
University of Ulsan
Ulsan University Hospital

Completed

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Tuberculosis | Tuberculosis, Pulmonary | Multi-drug Resistant Tuberculosis | Bronchoscopy | Transmission | Cavity | Acid Fast Bacilli Infection | Insolation

Korea, Republic of
Johns Hopkins University
Aurum Institute; KNCV Tuberculosis Foundation; Clinton Health Access Initiative...

Completed

Choice Architecture Based TB Preventive Therapy Prescribing (CAT)

HIV/AIDS | Tuberculosis

Malawi, Mozambique, Zimbabwe
Drugs for Neglected Diseases
Sanofi

Completed

Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage

Trypanosomiasis, African | Sleeping Sickness | Trypanosomiasis; Gambian

Congo, The Democratic Republic of the, Guinea
Gambat Institute of Medical Sciences

Completed

Treatment Adherence of Tuberculosis Medicines (TBAD)

Tuberculosis

Pakistan
Johns Hopkins University
Aurum Institute; UNITAID; KNCV Tuberculosis Foundation

Completed

Community Initiated Preventive Therapy for TB (CHIP-TB)

Tuberculosis

Ethiopia
Johns Hopkins University

Completed

Chepetsa TB - Reducing TB Among HIV-Infected Malawians

Tuberculosis

Malawi
Hasanuddin University
Chulalongkorn University

Completed

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

Resistance to Tuberculostatic Drugs | MDR Tuberculosis

Indonesia
Makerere University

Unknown

Impact of Mobile Health Interactive Software on Tuberculosis Outcomes; The Call for Life (CFLU-TB) Project (CFLU-TB)

Tuberculosis

Uganda
Università degli Studi dell'Insubria
Fondazione Salvatore Maugeri; Instituto Nacional de Enfermedades Respiratorias and other collaborators

Unknown

Respiratory Function in Patients With Post-tuberculosis Lung Impairment

Lung Diseases, Obstructive | Pulmonary Rehabilitation | Lung TB

Italy
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); Dr. D.Y. Patil...

Recruiting

Tuberculosis (TB) Aftermath

Tuberculosis (TB)

India
QIAGEN Gaithersburg, Inc

Withdrawn

QuantiFERON Access Clinical Performance Study Protocol

Tuberculosis (TB)
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Tuberculosis (TB)

Switzerland
GlaxoSmithKline
Corixa Corporation

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults

Tuberculosis (TB)

United States
Tatyana Zubkova

Completed

Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 Years

Tuberculosis Infection

Russian Federation
University of California, San Francisco
Johns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI); Makerere... and other collaborators

Active, not recruiting

TB Screening Improves Preventive Therapy Uptake (TB SCRIPT)

HIV | Latent Tuberculosis | Tuberculosis | Tuberculosis Prevention

Uganda
Archivel Farma S.L.
Parexel

Completed

Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection

Tuberculosis | Latent Tuberculosis Infection

South Africa
University of Michigan
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Development of a Multifunctional Rehabilitation Device for Persons With Parkinson's Disease

Parkinson Disease

United States
Elizabeth Glaser Pediatric AIDS Foundation
UNITAID; Kenya Ministry of Health; Ministry of Public Health, Cameroon

Completed

Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya

COVID-19

Cameroon, Kenya
Elizabeth Glaser Pediatric AIDS Foundation

Completed

TB Innovation Project: A Pre- and Post- Implementation Assessment (TIPPI) (TIPPI)

Tuberculosis | Pediatric

Cameroon, Congo, The Democratic Republic of the, Côte D'Ivoire, India, Kenya, Lesotho, Malawi, Tanzania, Uganda, Zimbabwe
Tuberculosis Research Centre, India
National Institutes of Health (NIH)

Recruiting

Comorbidities and Coinfections in Latent TB (COMBINE-TB)

Malnutrition | Latent Tuberculosis | Diabete Mellitus | Helminth Infection

India
ANRS, Emerging Infectious Diseases
European and Developing Countries Clinical Trials Partnership (EDCTP); European...

Recruiting

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression (DATURA)

Tuberculosis | HIV-1-infection | Immuno-Deficiency

Uganda, Cambodia, Cameroon, Guinea, Vietnam, Zambia
Charite University, Berlin, Germany

Completed

Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP) (LOKALE)

Infection Resistant to Multiple Drugs

Germany
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection (PREVENT TB)

Tuberculosis

United States, Canada, Spain, Brazil
University of Cape Town

Completed

Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM (LASER-TBM)

HIV-1-infection | Tuberculosis Meningitis

South Africa
University of Campania "Luigi Vanvitelli"
Federico II University

Completed

Colistin and Rifampicin for MDR-Acinetobacter (CoRAb)

Pneumonia, Ventilator-Associated | Hospital Acquired Pneumonia | Infection Due to Resistant Bacteria | Infection of Bloodstream | Infectious Disease of Abdomen
Germans Trias i Pujol Hospital
Archivel Farma S.L.

Completed

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

Tuberculosis | Latent Tuberculosis Infection

Spain
National Human Genome Research Institute (NHGRI)

Completed

Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study

Bipolar Disorder (BD) | Bipolar

United States
GlaxoSmithKline
Click-TB Consortium

Recruiting

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Tuberculosis

South Africa
International Myeloma Foundation
Janssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.

Active, not recruiting

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (ASCENT)

Smoldering Multiple Myeloma

United States
University Hospital, Strasbourg, France

Unknown

A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace

Tuberculosis

France
National Institute of Allergy and Infectious Diseases...

Terminated

Determining Risk in Latent Tuberculosis

Latent Tuberculosis

Korea, Republic of
International AIDS Vaccine Initiative
Universidad de Zaragoza; Biofabri, SLU

Not yet recruiting

A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in IGRA Positive Adolescents and Adults Living in a TB Endemic Region.

Tuberculosis (TB)
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
University of Oxford
Imaxio

Completed

Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

Tuberculosis (TB)

United Kingdom
Johns Hopkins Bloomberg School of Public Health
National Institute of Allergy and Infectious Diseases (NIAID); Perinatal HIV...

Completed

Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa (Kharitode TB)

Tuberculosis

South Africa
Huashan Hospital

Recruiting

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) (INSPIRE-TB)

Multidrug Resistant Tuberculosis

China
Beijing Chest Hospital

Recruiting

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Tuberculosis

China
Mahidol University

Completed

Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma

Asthma

Thailand
Huashan Hospital
Guizhou Center for Disease Control and Prevention

Recruiting

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Tuberculosis | Latent Tuberculosis Infection

China
London School of Hygiene and Tropical Medicine
Kamuzu University of Health Sciences

Completed

Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study) (ACT-TB)

Respiratory Tract Infections | Pneumonia | Tuberculosis

Malawi
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Air Force Military Medical University... and other collaborators

Completed

Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10

Tuberculosis
Shandong University
Tongji Hospital; Wuhan Union Hospital, China; Zhejiang University

Unknown

PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma (PCLE)

Diagnostic Yield of Gastric Neoplasia

China
Shanghai Jiatan Pharmatech Co., Ltd

Enrolling by invitation

Sudapyridine (WX-081) in RR/MDR/XDR-tuberculosis Patients (WISH)

Rifampicin-resistant Tuberculosis

China
National Institute of Allergy and Infectious Diseases...

Completed

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

HIV Infections | Tuberculosis

Brazil, United States, Kenya, Peru, South Africa, Thailand, Botswana, Haiti, Malawi, Zimbabwe

Search clinical trials for: Multi-drug resistant tuberculosis (MDR-TB)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations